13th Conference of Undiagnosed Diseases Network International / 5-7 September, 2024, Seoul, Korea / Seoul National University Children's Hospital, CJ Hall

Luncheon Symposium

Day 1 (November 14, Thu)

Luncheon Symposium 1 (Novartis Korea) 12:00-13:00ㅣRoom 5F-1 Novartis
Chair(s) Jongwon Ha (Seoul National University)
Speakers(s) Optimizing Immunosuppression: the Role of mTOR Inhibitors in Kidney Transplant Patients
Sangil Min (Seoul National University)

Day 2 (November 15, Fri)

Luncheon Symposium 2  (Astellas Pharma Korea, Inc.) 12:40-13:40ㅣRoom 3F-1 astellas
Chair(s) Sun Cheol Park (The Catholic University of Korea)
Gi-Won Song (Asan Medical Center)
Speakers(s) Risk Prediction of BK Viremia After Kidney Transplantation and the Impact of Immunosuppressant Strategies: Findings from the EMR Study Using Machine Learning
Hyunwook Kwon (Asan Medical Center)
Strategies of the Management of Hepatorenal Syndrome and the Use of the CNI for Long-Term Survival of Recipient
Jae Geun Lee (Yonsei University)

Day 3 (November 16, Sat)

Luncheon Symposium 3 (Chong Kun Dang Pharm.) 12:30-13:30ㅣRoom 3F-1 Chong Kun Dang Pharm.
Chair(s) Kyung-Suk Suh (Seoul National University)
Speakers(s) Efficacy and Safety of CertiroBell® Tablet (Everolimus) in Primary Living Donor Liver Transplant Recipients: A Comprehensive Review of Two Recent Studies
Deok-Gie Kim (Yonsei University)